Abstract:Background Metabolic reprogramming in cancer cells is likely to interact with the epigenetic landmarks, which may modulate tumorigenesis. However, the exact mechanism is still largely unknown. In our previous study, inhibition of activity of mechanistic target of rapamycin (mTORC1), a nutrient sensor that affects cellular metabolism, was able to attenuate the DNA methylation level. In this study, we aim to clarify the correlation between the metabolism and DNA methylation and evaluate their interactive roles in the pathogenesis of hepatocellular carcinoma (HCC). Methods We treated HCC cell lines with rapamycin to inhibit mTORC1 activity and performed immunofluorescence (IF) and Enzyme-linked immune sorbent assay (ELISA) to detect the levels of 5-methylcytosine (5-mC). Western-blot and IF assays were used to detect the protein levels of DNA methyltransferases (DNMTs) and RT-PCR was performed to test transcription of DNMTs. Cycloheximide was used to suppress the protein translation. Moreover, MG132 and BafA1 were used to inhibit the functions of ubiquitin-proteasome and autophagy-lysosome respectively to evaluate the effect of posttranslational modification for DNMTs degradation. Finally, we selected twenty liver cancer cell lines and combined western-blot and CCK8 assays to observe the association between mTORC1 inhibition-induced DNMTs degradation and cell viabilities. Results Rapamycin treatment reduced 5 mC levels in HCC cell lines. In parallel, mTORC1 inhibition attenuated the expressions of DNMT1. The subsequent experiments revealed that transcriptional regulation and posttranslational modification is not likely to participate in the process of DNMT1 degradation induced by mTORC1 inhibition. However, cycloheximide half-life assay indicated that mTORC1 might adjust the expression DNMT1 through regulating initial translational efficiency. We found that mTORC1-mediated DNMT1 degradation is closely linked to cell proliferation. Conclusions In conclusion, we demonstrated that mTORC1 could affect DNA methylation levels in HCC probably through regulating DNMTs expression. Besides, this interactive role seems to be closely linked to HCC cell viability. Investigation of the relationship between mTORC1 signalling and DNA methylation will deepen our insight on the pathogenesis of HCC and develop a novel therapeutic strategy for HCC patients.

Effects of mTOR Signaling Pathway Inhibitor and DNA Methyltransferase Inhibitor on Syk Expression in Human Gastric Cancer Cell Lines

The effects of 5-Aza-2-deoxycytidine, a methylation inhibitor, on the proliferation of androgen-sensitive prostate cancer cell line, and on the regulation of methylation of glutathione s-transferase P1 and retinoic acid receptorβ2 gene

Mammalian Target of Rapamycin Pathway Inhibition Enhances the Effects of 5-Aza-dc on Suppressing Cell Proliferation in Human Gastric Cancer Cell Lines

[The Relationship of Mtor Signaling Pathway and Histone Acetylation in Human Gastric Cancer Cell Lines].

Inhibition of Mtor Signalling Potentiates the Effects of Trichostatin A in Human Gastric Cancer Cell Lines by Promoting Histone Acetylation

DNA Methyltransferase Inhibitor and Rapamycin Synergistically Modulate Cell Cycle and Mammalian Target of Rapamycin Signaling Pathway for Human Colorectal Cancer Cells

Effects of inhibiting PI3K/AKT/mTOR signaling pathway by LY294002 on gastric cancer MGC-803 cells

[Synergistic Effect of Rapamycin (RPM) and PD98059 on Cell Cycle and Mtor Signal Transduction in Human Colorectal Cancer Cells].

Regulation of DNA Methylation on Expression of Genes in Human Gastric Cancer Cell Lines

IDDF2018-ABS-0140 the Crosstalk of MTORC1 and DNA Methylation in Hepatocellular Carcinoma

Effects of 5-Aza-dcr and TSA on Methylation of Transcription Regulation of Syk Gene in Colorectal Cancer Cell Line

The Activation of Mtor Signalling Modulates DNA Methylation by Enhancing DNMT1 Translation in Hepatocellular Carcinoma.

Inhibition of DNA Methyltransferase Induces G2 Cell Cycle Arrest and Apoptosis in Human Colorectal Cancer Cells Via Inhibition of JAK2/STAT3/STAT5 Signalling

Effects of 5-Aza-2'-deoxycitydine on Expression of RASSF1A Gene in Human Ovarian Cancer Cell Line

Effect of inhibitory action of LY294002 in the PI3K/AKT signaling pathway on gastric adenocarcinoma SGC-7901 cells

Synergistic Effects Between Mtor Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells

Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer

Activated Spleen Tyrosine Kinase Promotes Malignant Progression of Oral Squamous Cell Carcinoma Via Mtor/s6 Signaling Pathway in an ERK1/2-independent Manner

5-Aza-2 '-Deoxycitydine Induces Demethylation and Up-Regulates Transcription of P16(Ink4a) Gene in Human Gastric Cancer Cell Lines

The Expression of Tumor-associated Genes and Methylation in Human Gastric Cancer Cells